Search

everythinglearnresearchcommunity

for

Search:↓

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Cinnamaldehyde helps bone healing initially but may slow healing later unless combined with DHT treatment.

Moringa seed oil helped hair growth in rabbits, with the highest dose being most effective.

Ziziphus spina-christi leaf extract lowered blood sugar and protected organs in diabetic rats.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Microsechium helleri extract has antioxidant, anti-inflammatory, antidiabetic, and heart-protective benefits.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

The anti-CXCL4 antibody helps mice grow hair faster and prevents hair loss.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.

A boy on a ketogenic diet and anti-epileptic drugs developed skin issues due to stopping vitamin supplements, which improved with proper supplementation.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

PLD is an effective and safer alternative for treating breast cancer.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.